ATE141290T1 - M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen - Google Patents

M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen

Info

Publication number
ATE141290T1
ATE141290T1 AT90902943T AT90902943T ATE141290T1 AT E141290 T1 ATE141290 T1 AT E141290T1 AT 90902943 T AT90902943 T AT 90902943T AT 90902943 T AT90902943 T AT 90902943T AT E141290 T1 ATE141290 T1 AT E141290T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
csf
conformational epitope
recognize
csf monoclonal
Prior art date
Application number
AT90902943T
Other languages
English (en)
Inventor
Robert F Halenbeck
Kirston E Koths
Joseph W Wrin
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ATE141290T1 publication Critical patent/ATE141290T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90902943T 1989-02-10 1990-01-17 M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen ATE141290T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31004289A 1989-02-10 1989-02-10

Publications (1)

Publication Number Publication Date
ATE141290T1 true ATE141290T1 (de) 1996-08-15

Family

ID=23200753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902943T ATE141290T1 (de) 1989-02-10 1990-01-17 M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen

Country Status (9)

Country Link
US (1) US5491065A (de)
EP (1) EP0457804B1 (de)
JP (1) JP3001969B2 (de)
AT (1) ATE141290T1 (de)
CA (1) CA2008817C (de)
DE (1) DE69028095T2 (de)
DK (1) DK0457804T3 (de)
ES (1) ES2091816T3 (de)
WO (1) WO1990009400A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096540A (en) * 1996-09-30 2000-08-01 Becton Dickinson And Company Differentiation of granulocytic and monocytic progenitor cells
US6363129B1 (en) 1998-11-09 2002-03-26 Broadcom Corporation Timing recovery system for a multi-pair gigabit transceiver
AU1759501A (en) * 1999-11-08 2001-06-06 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Method of treating a viral infection using antagonists of macrophage colony stimulating factor
US7108852B2 (en) 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
US20110091451A1 (en) * 2002-11-15 2011-04-21 Kavanaugh William M Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
WO2004045532A2 (en) * 2002-11-15 2004-06-03 Chiron Corporation Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
AR045563A1 (es) * 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
DK2311873T3 (en) 2004-01-07 2018-11-26 Novartis Vaccines & Diagnostics Inc M-CSF-SPECIFIC MONOCLONAL ANTIBODY AND APPLICATIONS THEREOF
WO2005123966A2 (en) * 2004-06-12 2005-12-29 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
CA2600601A1 (en) * 2005-03-08 2006-09-14 Pharmacia & Upjohn Company Llc Anti-m-csf antibody compositions having reduced levels of endotoxin
WO2007016285A2 (en) * 2005-07-28 2007-02-08 Novartis Ag M-csf specific monoclonal antibody and uses thereof
EP2277916A3 (de) * 2005-07-28 2011-04-27 Novartis AG Verwendung von Antikörper zu M-CSF
AU2007205048B2 (en) * 2006-01-05 2013-07-04 Novartis Ag Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
JP2014520873A (ja) 2011-07-18 2014-08-25 ザ ユニバーシティ オブ メルボルン ｃ−Ｆｍｓアンタゴニストの使用
SG11201507871XA (en) 2013-04-12 2015-10-29 Morphosys Ag Antibodies targeting m-csf

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504586A (en) * 1983-02-03 1985-03-12 Amgen Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
JP2579981B2 (ja) * 1986-05-06 1997-02-12 ジェネティックス・インスチチュート・インコーポレーテッド Ｍ―ｃｓｆの生産方法
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1

Also Published As

Publication number Publication date
EP0457804A1 (de) 1991-11-27
JPH04503155A (ja) 1992-06-11
DK0457804T3 (da) 1996-09-23
JP3001969B2 (ja) 2000-01-24
US5491065A (en) 1996-02-13
WO1990009400A1 (en) 1990-08-23
DE69028095D1 (de) 1996-09-19
CA2008817C (en) 2000-03-14
ES2091816T3 (es) 1996-11-16
CA2008817A1 (en) 1990-08-10
DE69028095T2 (de) 1997-02-06
EP0457804B1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
ATE141290T1 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
EP0914155A4 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
FI944509A0 (fi) Interferonireseptorin vastaisia monoklonaalisia vasta-aineita, joilla on neutralisoivaa aktiivisuutta tyypin I interferonia vastaan
ATE250426T1 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
DE69033735D1 (de) Varianten von adhäsionsmoleküle für blutplättchen
NL188544C (nl) Reagens voor immunochemische analysemethoden, uitgevoerd in aanwezigheid van een waterige vloeistof.
ES2046462T3 (es) Marcadores de activacion de celulas "t".
DE50114906D1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur stimulation von blutzellen, welche kein cd28 tragen
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
FI885169L (fi) Monoklonaalinen vasta-aine, joka tunnistaa N-asetyylineuramiinihapon -järjestyksessä, sen käyttö ja sitä tuottava hybridooma
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
DE3886545D1 (de) Monoklonale human-antikörper, spezifisch für rh(d).
ATE154395T1 (de) Monoklonale antikörper
KR900017549A (ko) 암의 혈청진단법
ES8606500A1 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
EP0721958A3 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee